Noveris Health Sciences is trading 6.5% down today at CA$1.01 amid ongoing volatility and profit-taking following a sharp late-July pullback.
- No fresh company-specific headlines or regulatory filings were identified to account for the move.
- The decline occurs despite the broader biotech sector trading modestly higher.
- The price action reflects typical volatility for a micro-cap biotech name with no discrete catalyst.